Crossmark

Effectiveness of Trimetazidine in Patients with Chronic Heart Failure Stratified by the Expression of Soluble Suppression of Tumorigenicity-2 (sST2): A Prospective Cohort Study

Crossref DOI link: https://doi.org/10.1007/s12325-022-02315-x

Published Online: 2022-10-12

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Min, Zhu

Xuelu, Liu

Ran, Zhang

Qiuhong, Shu

Yong, Meng
Funding

Funding for this research was provided by:

Joint special fund of Yunnan science and technology department - Kunming medical university (2018FE001(-056))
License Information

Text and Data Mining valid from 2022-10-12

Version of Record valid from 2022-10-12
More Information

Article History

Received: 2 February 2022

Accepted: 12 May 2022

First Online: 12 October 2022

Document is current

Any future updates will be listed below